10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Diagnostic signature for heart failure with preserved ejection fraction (HFpEF): a machine learning approach using multi-modality electronic health record data

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Heart failure with preserved ejection fraction (HFpEF) is thought to be highly prevalent yet remains underdiagnosed. Evidence-based treatments are available that increase quality of life and decrease hospitalization. We sought to develop a data-driven diagnostic model to predict from electronic health records (EHR) the likelihood of HFpEF among patients with unexplained dyspnea and preserved left ventricular EF.

          Methods and results

          The derivation cohort comprised patients with dyspnea and echocardiography results. Structured and unstructured data were extracted using an automated informatics pipeline. Patients were retrospectively diagnosed as HFpEF (cases), non-HF (control cohort I), or HF with reduced EF (HFrEF; control cohort II). The ability of clinical parameters and investigations to discriminate cases from controls was evaluated by extreme gradient boosting. A likelihood scoring system was developed and validated in a separate test cohort. The derivation cohort included 1585 consecutive patients: 133 cases of HFpEF (9%), 194 non-HF cases (Control cohort I) and 1258 HFrEF cases (Control cohort II). Two HFpEF diagnostic signatures were derived, comprising symptoms, diagnoses and investigation results. A final prediction model was generated based on the averaged likelihood scores from these two models. In a validation cohort consisting of 269 consecutive patients [with 66 HFpEF cases (24.5%)], the diagnostic power of detecting HFpEF had an AUROC of 90% (P < 0.001) and average precision of 74%.

          Conclusion

          This diagnostic signature enables discrimination of HFpEF from non-cardiac dyspnea or HFrEF from EHR and can assist in the diagnostic evaluation in patients with unexplained dyspnea. This approach will enable identification of HFpEF patients who may then benefit from new evidence-based therapies.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s12872-022-03005-w.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: not found
          • Article: not found

          2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

            The rapid technological developments of the past decade and the changes in echocardiographic practice brought about by these developments have resulted in the need for updated recommendations to the previously published guidelines for cardiac chamber quantification, which was the goal of the joint writing group assembled by the American Society of Echocardiography and the European Association of Cardiovascular Imaging. This document provides updated normal values for all four cardiac chambers, including three-dimensional echocardiography and myocardial deformation, when possible, on the basis of considerably larger numbers of normal subjects, compiled from multiple databases. In addition, this document attempts to eliminate several minor discrepancies that existed between previously published guidelines. Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2015. For permissions please email: journals.permissions@oup.com.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Empagliflozin in Heart Failure with a Preserved Ejection Fraction

              Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction are uncertain.
                Bookmark

                Author and article information

                Contributors
                ajay.shah@kcl.ac.uk
                Journal
                BMC Cardiovasc Disord
                BMC Cardiovasc Disord
                BMC Cardiovascular Disorders
                BioMed Central (London )
                1471-2261
                26 December 2022
                26 December 2022
                2022
                : 22
                : 567
                Affiliations
                [1 ]GRID grid.13097.3c, ISNI 0000 0001 2322 6764, King’s College London British Heart Foundation Centre of Excellence, School of Cardiovascular and Metabolic Medicine and Sciences, , King’s College London, ; James Black Centre, 125 Coldharbour Lane, London, SE5 9NU UK
                [2 ]GRID grid.13097.3c, ISNI 0000 0001 2322 6764, Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, , King’s College London, ; London, UK
                [3 ]GRID grid.83440.3b, ISNI 0000000121901201, Health Data Research UK London, Institute of Health Informatics, , University College London, ; London, UK
                [4 ]GRID grid.429705.d, ISNI 0000 0004 0489 4320, King’s College Hospital NHS Foundation Trust, ; London, UK
                [5 ]GRID grid.451056.3, ISNI 0000 0001 2116 3923, NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, ; London, UK
                Article
                3005
                10.1186/s12872-022-03005-w
                9791783
                36567336
                3ac8d35f-e022-4c63-90cb-4a9e99de68a8
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 15 March 2022
                : 12 December 2022
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100000265, Medical Research Council;
                Funded by: FundRef http://dx.doi.org/10.13039/100014013, UK Research and Innovation;
                Award ID: MR/S00310X/1
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2022

                Cardiovascular Medicine
                hfpef,machine learning,dyspnea
                Cardiovascular Medicine
                hfpef, machine learning, dyspnea

                Comments

                Comment on this article